1st Quarter - Report · 2026

Filing UUID: 649e6ccb-fd7b-4954-9062-906e9fd60b4f
Type: Q1 — 1st Quarter - Report
Period: first_quarter
Year: 2026
Posted: 2026-04-06 19:13:58
Income (reported): —
Expenses (reported): —
Filing document: Open on lda.senate.gov

Registrant (lobbying firm)

CHAMBER HILL STRATEGIES

public policy consulting

Contact: JENNIFER BELL
Phone: +1 202-470-4944
Address: zip:22207, city:Arlington, state:VA, street:3325 N Kensington Street

Client

OS THERAPIES

biotechnology company

State: NY
Country: US
Effective date: 2025-09-08

Issues lobbied + lobbyists

`PHA` — Pharmacy

cancer immunotherapy and antibody treatment; osteosarcoma

Lobbyists: JENNIFER BELL (covered position: Health Policy Advisor, Sen. Finance Committee; Legislative Assistant, Rep. John Thune (R-SD)); SHAWN FRIESEN (covered position: Legislative Director, Rep. Mac Collins (R-GA)); Legislative Assistant, Rep. Tom Ewing (IL-15); Clerk, House Judiciary Committee); JENNIFER HOLLAND (covered position: Scheduler, Rep. Mary Kaptur (OH-09); Operations Director, Rep. Donald Norcross (NJ-01); Scheduler, Rep. Debbie Dingell (MI-06))

Government entities lobbied: Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

`HCR` — Health Issues

cancer immunotherapy and antibody treatment; osteosarcoma

Lobbyists: JENNIFER BELL (covered position: Health Policy Advisor, Sen. Finance Committee; Legislative Assistant, Rep. John Thune (R-SD)); JENNIFER HOLLAND (covered position: Scheduler, Rep. Mary Kaptur (OH-09); Operations Director, Rep. Donald Norcross (NJ-01); Scheduler, Rep. Debbie Dingell (MI-06))